Categories: Washington Post

2 9/19/2018

One woman’s account of spinal cord stimulator skips realities of medical device safety in U.S.

6/27/2018

FDA approves new marijuana-derived drug, but was the evidence solid? Washington Post doesn’t say

4/17/2018

Immunotherapy prolongs survival, but at what cost? Washington Post needed more on treatment downsides

1/31/2018

Washington Post story on hyperbaric therapy for head injuries notes uncertain benefit–but not potential harms

12/12/2017

Gene therapy and hemophilia: Washington Post wisely tells readers ‘the study has some limitations’

11/14/2017

‘Regular painkillers work as well as opioids for fractures,’ but is this new information?

10/24/2017

Washington Post wisely quantifies severe side effects and deaths from CAR-T cell therapy

8/31/2017

Washington Post’s otherwise well-reported story on ecstasy for PTSD skirts evidence discussion

7/18/2017

Washington Post wisely notes that CAR T-cell therapy may cost at least $300,000

7/6/2017

Washington Post deftly examines lack of evidence for a fuzzy area of psychiatry: animal therapy

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Alan Cassels @AKECassels·

Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597

Reply on Twitter 1361431489326407680 Retweet on Twitter 13614314893264076806 Like on Twitter 13614314893264076808 Twitter 1361431489326407680

Retweet on Twitter HealthNewsReview.org Retweeted

RxISK @RxISK·

A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.

It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123

Reply on Twitter 1361420459284131843 Retweet on Twitter 13614204592841318439 Like on Twitter 136142045928413184318 Twitter 1361420459284131843

HealthNewsReview.org @HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532 Retweet on Twitter 13602149497049825325 Like on Twitter 136021494970498253210 Twitter 1360214949704982532